AI Trust Score, Reviews & Company Verification
Is this your company? Claim the Enable Medicine profile to verify ownership and manage company-provided details.
Independent company assessment
8.5/10B · Solid
22 indexed evidence signals reviewed
AI Comparison
Safe Entity66% Confidence
Based on 5 polled AI models
- GeminiGoogle DeepMindSafe80%Confidence
- GrokxAISafe68%Confidence
- DeepSeekDeepSeekSafe90%Confidence
- GLMZ.aiSafe45%Confidence
Key stats
- Sector
- Biotechnology Companies
- Headquarters
- US
- Domain
- enablemedicine.com
- Domain history
- Not available
- Risk tier
- Moderate
- Assessed
- Jul 29, 2026
This profile is waiting for Enable Medicine
Enable Medicine has not claimed this ShouldEye profile yet.
Until an authorized representative verifies ownership, ShouldEye AI independently maintains this overview from public records, reviews, regulatory filings, and live trust signals. Nothing on this page has been approved by the brand.
- Respond to reviews and experiences in your voice
- Replace this placeholder with your official brand message
- Take control of how your trust score is presented
Free verification for authorized company representatives
Enable Medicine is a biotechnology company that creates detailed biological maps and cellular atlases to accelerate drug discovery, leveraging generative AI and spatial biology technologies.
- Headquarters
- US
Full intelligence report for Enable Medicine
Enable Medicine demonstrates strong operational credibility through exceptional regulatory compliance, consumer reviews, and customer service, supported by responsible advertising practices that reinforce its verified status. Its legal and privacy frameworks are comparatively moderate, suggesting room for improved policy transparency or data protections that keep the overall profile from matching the strength of its reputation and consumer-facing operations.
- The regulatory intelligence found no direct enforcement actions or compliance failures specific to Enable Medicine.
- Public reputation is strong, highlighted by acquisition by General Inception and strategic partnerships with General Inception and BioChain, and recognition as a leader in AI‑led biological data analysis for drug discovery.
- The Terms of Use provide a clear and accessible cancellation process for automatic renewals and transparent fee disclosures.
- The Terms of Service contain one‑sided provisions: mandatory binding arbitration with class‑action and jury‑trial waivers (except a limited small‑claims carve‑out), broad indemnification shifting legal costs to users, unilateral term modifications without explicit notice, a perpetual license to user data for R&D and sublicensing, and a low liability cap of $100 or one month’s fees.
- The privacy policy shares personal data with third‑party advertising and marketing partners for interest‑based advertising and profiling, collects general location information without explicit consent, lacks defined data retention periods, and does not disclose or allow opt‑out for using personal data to train AI/ML models.
- The policy provides limited mechanisms for data deletion, requiring users to contact the company rather than offering self‑service deletion for all data, and does not specify clear breach notification procedures.
Connect with Enable Medicine
Find us across the web
Links found on the company website.